New Pill May Tame Sleep Apnea, Cutting Breathing Pauses
A European double-blind trial with 298 participants found the drug sulthiame reduced breathing interruptions by up to 47% and improved overnight oxygen levels in adults with moderate to severe sleep apnea, suggesting a pill-based alternative to CPAP, though longer studies are needed to assess long-term safety and sustained effects.
